The decision to expand blood screening in the US was based on concerns about more cases of local transmission in Florida, the growing number of travel-related infections and concerns that Zika-tainted blood could unwittingly be given to a pregnant woman, putting her unborn baby at a risk of severe birth defects, an official release said yesterday.
The Food and Drug Administration (FDA) says all those areas are currently in compliance with blood screening, but that expanded testing is now needed.
"As new scientific and epidemiological information regarding Zika virus has become available, it's clear that additional precautionary measures are necessary," FDA's acting chief scientist, Luciana Borio said.
The expansion of testing won't happen all at once. The FDA is advising blood establishments in 11 states to begin the testing within the next four weeks.
The states include Alabama, Arizona, California, Georgia, Hawaii, Louisiana, Mississippi, New Mexico, New York, South Carolina and Texas.
These states are in proximity to areas where Zika is actively spreading via mosquitoes or where there are a significant number of cases related to other exposures, including sexual transmission, the release said.
Within 12 weeks, blood facilities in all states should be testing donations for Zika.
"The transfusion of a pregnant woman with blood infected with the Zika virus could have terrible consequences," Peter Marks, Director of FDA Centre for Biologics Evaluation and Research said.
The current Zika outbreak was first detected in Brazil last year and has since spread across the Americas.
In Brazil, Zika has been linked to more than 1,800 cases of microcephaly and US officials expect as many as 270 cases in Puerto Rico, where local transmission of the virus is widespread.
"Over 8,000 travel-associated and over 2,000 non-travel associated cases of Zika have been reported in the United States and US territories," Marks said.
Given the frequency of travel of individuals within the United States, he said there was a risk that people without symptoms of Zika could donate blood and transmit the virus.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)